For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| All Participants: Essential Amino Acid (EAA) Supplement vs Placebo | All participants completed two 4-week phases of the study in random order with a washout period in between each phase of the study. Each phase consisted of either: 4 weeks of Essential Amino Acid Supplement- 15g 2/day followed by 4 weeks: Placebo- 15g 2/day or vice versa. We are comparing the differences in the essential amino acid vs placebo. | 0 | None | 0 | 27 | 0 | 27 | View |